A novel microencapsulated peptide vaccine against hepatitis B

Vaccine

Volumn 19, Issue 23-24, 2001, Pages 3292-3300

  Moynihan, Jennifer S ^a   Jones, David H ^b   Farrar, Graham H ^b   Howard, Colin R ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Hepatitis B virus; Microspheres; Synthetic peptide

Indexed keywords

FREUND ADJUVANT; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; IMMUNOGLOBULIN G1; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CELL STIMULATION; DOSE RESPONSE; FEASIBILITY STUDY; HEPATITIS B VIRUS; IMMUNIZATION; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; CAPSULES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; IMMUNOGLOBULIN G; LACTIC ACID; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POLYGLYCOLIC ACID; POLYMERS; VACCINES, SUBUNIT;

EID: 0035971960     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00540-5     Document Type: Article

References (28)

1. Hepatitis viruses
2. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine
3. Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells
4. Peptide vaccine against canine parvovirus: Identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence
5. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4
6. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide
7. First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs
8. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide containing B- and T-cell epitopes from the fusion protein of measles virus
9. Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins
10. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos
11. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- nd T-cell epitopes induces protection in mice
12. Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides
13. A topological model for hepatitis B surface antigen
14. A synthetic peptide spontaneously self-assembles to reconstruct a group-specific, conformational determinant of hepatitis B surface antigen
15. Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen
16. Immunological characteristics of a recombinant hepatitis B virus-derived multiple-epitope polypeptide: A study in polyvalent vaccine design
17. A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody
18. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles
19. Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen
20. 14C-labeled tetanus toxoid
21. Adjuvants for human vaccines - Current status, problems and future prospects
22. The distribution of protein associated with poly(dl-lactide co-glycolide) microparticles and its degradation in simulated body fluids
23. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly (d,l-lactide-co-glycolide) microparticles
24. A 48-mer synthetic peptide analogue of the hepatitis B virus (HBV) 'a' determinant induces an anti-HBs antibody response after a single injection
25. Solid phase peptide synthesis I. The synthesis of a tetrapeptide
26. Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide
27. The predicted pattern of emergence of vaccine-resistant hepatitis B: A cause for concern?
28. Biodegradable microspheres as a vaccine delivery system